CpG 10101

Drug Profile

CpG 10101

Alternative Names: Actilon; CpG-10101

Latest Information Update: 04 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Coley Pharmaceutical Group
  • Class Antivirals; Oligonucleotides
  • Mechanism of Action Toll-like receptor 9 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Hepatitis C

Most Recent Events

  • 04 Aug 2009 No development reported - Phase-II for Hepatitis C in USA (SC)
  • 01 Jan 2008 Coley Pharmaceutical Group has been acquired by Pfizer
  • 22 Jan 2007 CpG 10101 is available for licensing (http://www.coleypharma.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top